• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Myocardial Infarction (1969); Thrombosis (2100); Cardiogenic Shock (2262); Stenosis (2263); Injury (2348)
Event Date 01/01/2019
Event Type  Injury  
Manufacturer Narrative
Journal article: unprotected left main percutaneous coronary intervention: prognostic value of syntax score ii journal: tunisie medicale year: 2019 ref: (b)(4).(b)(4).Average age, majority gender, date of publication medication: dual antiplatelet therapy there is no information to suggest the device caused or contributed to the death events.Deaths are common occurrences in clinical studies, however the cause(s) of death are often not characterized or clearly associated with a particular product.Therefore, deaths will not be considered reportable unless clearly stated as being associated with a medtronic device.If information is provided in the future, a supplemental report will be issued.
 
Event Description
From january 2012 to december 2017, 150 consecutive patients with unprotected lm-cad treated by pci were prospectively analyzed in this, ¿all-comers¿, monocentric registry.Lesion characteristics included bifurcation, calcification, total occlusion and thrombus.Zotarolimus eluting stents were implanted in 64 patients.In hospital adverse outcomes consisted of four deaths (3 for cardiogenic shocks and one for major femoral access site bleeding) and one non-fatal mi due to a definite subacute stent thrombosis.Adverse events from follow-up at 13.4 months included all-cause death in 16 patients, among them 12 were adjudicated as cardiac deaths, mi occurred in 5 cases and tlr in 14 cases.In-stent restenosis was observed in 13 patients and a total of 4 patients experienced definite or probable stent thrombosis.Tvr was reported in 19 cases.Cerebrovascular accident complicated follow-up in 2 patients.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE INTEGRITY RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9389978
MDR Text Key168586711
Report Number9612164-2019-04938
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeTS
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 11/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/31/2019
Initial Date FDA Received11/28/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
-
-